The total occurrence of HCC was significantly lower in group 1 than in group 2 (p < 0.001), suggesting that a normalized ALT within 1 year of starting antiviral medicines decreases the risk of developing HCC [40]. This evidence concerns the gene GPT and hepatocellular carcinoma.